All News

11/03 Hester Biosciences Gets Board Nod to Divest 43.8% Stake in Subsidiary; Shares Up 3% MT
11/03 Hester Biosciences approves divestment of 43.81% equity in Texas Lifesciences RE
11/03 Ticop Life Private Limited entered into an agreement to acquire an additional 43.81% stake in Texas Laboratories from Hester Biosciences Limited for INR 92 million. CI
30/01 Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
30/01 Hester Biosciences Limited, Q3 2026 Earnings Call, Jan 30, 2026
30/01 Hester Biosciences re-appoints Rajiv Gandhi as CEO & MD RE
24/01 Hester Biosciences Limited Receives the Manufacturing License from the Food & Drugs Control Administration CI
20/11 Hester Biosciences says Ashish Desai appointed as chief financial officer RE
20/11 Hester Biosciences Appoints CFO MT
20/11 Hester Biosciences Limited Appoints Ashish Desai as Key Managerial Personnel, with Effect from 20 November 2025 CI
20/11 Hester Biosciences Limited Appoints Ashish Desai as Chief Financial Officer, with Effect from 20 November 2025 CI
14/11 Hester Biosciences CFO Resigns MT
12/11 Indian Equities Extend Winning Run on NDA Exit Poll Boost, Global Optimism MT
12/11 Hester Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
12/11 Hester Biosciences Limited, Q2 2026 Earnings Call, Nov 12, 2025
12/11 Hester Biosciences' Consolidated Profit Declines in Fiscal Q2; Shares Down 3% MT
06/25/06 For final dividend FA
01/25/01 Hester Biosciences Consolidated Net Profit Jumps in Fiscal Q1; Shares Jump 12% MT
01/25/01 Hester Biosciences Limited, Q1 2026 Earnings Call, Aug 01, 2025
01/25/01 Hester Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
09/25/09 Hester Biosciences Limited, Q4 2025 Earnings Call, May 09, 2025
09/25/09 Hester Biosciences Limited Proposes Dividend for the Financial Year Ended 31 March 2025, Payable on or After19 August 2025 CI
09/25/09 Hester Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2025 CI
14/25/14 Hester Biosciences Limited Approves Shifting of Registered Office CI
30/25/30 Hester Biosciences Limited, Q3 2025 Earnings Call, Jan 30, 2025
No results for this search
  1. Stock Market
  2. Equities
  3. HESTERBIO Stock
  4. News Hester Biosciences Limited
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW